PAR 1.92% 25.5¢ paradigm biopharmaceuticals limited..

I've been a shareholder in PME for over a decade now. My...

  1. 396 Posts.
    lightbulb Created with Sketch. 79
    I've been a shareholder in PME for over a decade now. My impression is that PME stuck to principles of excellent governance, staff and financial management and when they made a mistake, they corrected it quickly. This is reflected in C-suite stability, timeline reliability, financial planning and much more. This is in obvious contrast to PAR which actually has a much more promising product but won't capture its potential unless it commits to lifting its game at both management and governance levels.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.005(1.92%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $261.4K 990.7K

Buyers (Bids)

No. Vol. Price($)
1 9999 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 9445 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.